Genis
Genis is a biotechnology company that develops therapeutic chitin derivatives derived from shrimp shells for pharmaceutical and medical applications. The company operates three product platforms focused on treating inflammatory diseases like Rheumatoid arthritis and asthma, creating orthobiologic medical devices such as 3D-printed bone implants, and producing dietary supplements for humans and animals. Their research centers on the therapeutic properties of chitooligosaccharides and proprietary ChitoBiomer technology for bone tissue formation.
Funding summary
- Total raised
- €16.0M
- Funding rounds
- 1
Investors in Genis
Investors on record for Genis. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Genis?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors